MEASUREMENTS OF CELLULAR VIABILITY: A COMPARATIVE STUDY OF NEUTRAL RED AND RADIOACTIVE SULFATE IN THE EXAMINATION OF THE VIABILITY OF CARTILAGE

W. H. Lee,R. Hagerty,H. L. Braid

DOI: https://doi.org/10.1097/00006534-196009000-00003

1960-09-01

Abstract:

What problem does this paper attempt to address?

The Potentially Therapeutic Role of EPAC in Curbing the Process of Idiopathic Pulmonary Fibrosis Via Differential Cellular Pathways

Xinwei Cao,Yajun Li,Jianrong Shi,Huifang Tang

DOI: https://doi.org/10.2147/jir.s296382

IF: 4.5

2021-01-01

Journal of Inflammation Research

Abstract:Idiopathic pulmonary fibrosis (IPF) is a chronic progressive fibrosis disease caused by genetic susceptibility (causative) and other indirect risk factors such as smoking, micro-aspiration and air pollution. Repeated damage of lung epithelial cells can cause fibroblast activation and excessive collagen will lead the scar formation and severe fibrosis. It has been decades since drugs for the treatment of IPF were developed, but clinical choices were limited. Exchange Protein directly Activated by cAMP (EPAC), as a newly emerging cAMP (adenosine 3',5'-cyclic monophosphate) downstream molecule, plays a vital role in the cellular pathways of IPF such as inhibiting fibroblast proliferation, stress fiber formation and epithelium cell adhesion, so it may be a novel target for drug development and treatment for curbing IPF. Here, we hypothesize that EPAC may participate in the signaling pathways related to IPF in different cell types (fibroblasts; airway smooth muscle cells; vascular endothelial cells; lung epithelial cells; macrophages; mesenchymal stem cells; T cells), thereby playing a potentially therapeutic role in resisting the process of fibrosis. We summarize the current correlation between EPAC and IPF in these different cell types, and further insights into EPAC will help to optimize the pharmacological treatment for IPF.
Aged alveolar epithelium contributes to inflammaging and reduced stem cell function in the lung

Mareike Lehmann,Qiangjiang Hu,Yan Hu,Meshal Ansari,Ricardo Pineda,William Janssen,Fabian Theis,Herbert Schiller,Melanie Koenigshoff

DOI: https://doi.org/10.1183/13993003.congress-2021.OA1373

IF: 24.3

2021-01-01

European Respiratory Journal

Abstract:Introduction: Aging is a major risk factor for the development of Idiopathic Pulmonary Fibrosis (IPF), and several aging mechanisms, such as inflammaging and cellular senescence contribute to IPF pathogenesis. However, it remains unknown which mechanisms drive cellular senescence and inflammaging and how these processes are linked. Methods: Single Cell RNA Sequencing (scRNAseq) was performed on EpCAM-enriched cells from IPF and donor lungs, RNAseq, qPCR, flow cytometry and organoid assays were applied to characterize ATII cells from 3 months and 18 months old wild-type or WNT-reporter mice. ATII cells were induced to senescence monitored by qPCR and senescence-associated ß-Galactosidase activity. Inflammatory mediators were analyzed by ELISA. Results: ScRNAseq revealed a concomitant enrichment of senescence and inflammaging in distinct cell populations in IPF. Bulk RNAseq of aged ATII cells exposed overlapping inflammaging and senescence signatures as well as increased WNT/β-catenin activity. Treatment of primary ATII cells with DNA damage (X-ray or bleomycin) or chronic canonical (but not non-canonical) WNT activation induced senescence and the secretion of inflammaging-related mediators such as Interleukin-6. Notably, induction of senescence in ATII cells reduced their progenitor cell function in a dose-dependent manner as assessed by their capacity to form organoids. Conclusions: These results suggest a potential impact of cellular senescence and WNT signaling on inflammaging and progenitor cell function. Further analysis of single cell data from IPF patients will give insight into senescence-driven molecular mechanisms to induce inflammaging in aberrant cell types in IPF.
Prolonged WNT/ß-catenin signaling induces cellular senescence in aging and pulmonary fibrosis

M Lehmann,Q Hu,Y Hu,R Costa,M Ansari,R Pineda,W Janssen,F Theis,H Schiller,M Königshoff

DOI: https://doi.org/10.1183/23120541.LSC-2020.81

IF: 4.239

2020-01-01

ERJ Open Research

Abstract:Introduction: Idiopathic Pulmonary Fibrosis (IPF) is an age-related disease, which displays several hallmarks of aging, such as cellular senescence. The lung epithelium represents a major site of tissue injury in IPF resulting in functional changes including aberrant activity of the developmental WNT/β-catenin pathway. The potential impact of WNT/β-catenin signaling on epithelial senescence in aging and IPF remains elusive. Methods: Single Cell RNA Sequencing (scRNAseq) from EpCAM-enriched cell populations was performed from IPF and donor lungs. RNAseq, qPCR and flow cytometry was applied to characterize ATII cells from young (3 months) and old (18 months) wild-type or WNT-reporter mice, respectively. Progenitor cell potential was investigated by organoid assay. ATII cells were treated with WNT3A for up to 7 days. Cellular senescence was monitored by qPCR and senescence-associated s-Galactosidase activity. Results: ScRNAseq revealed a concomitant enrichment of both WNT/β-catenin signaling and cellular senescence in distinct cell populations in IPF. Similarly, aged ATII cells showed increased cellular senescence and increased WNT/β-catenin activity. Moreover, aged ATII cells exhibit an impaired organoid forming capacity. Bulk RNA sequencing revealed 416 differentially expressed genes in aged ATII cells, many of which are further known to be dysregulated in fibrosis. Chronic WNT/β-catenin activation induced cellular senescence in primary ATII cells. Simultaneously, chronic but not acute WNT activation induced a profibrotic state with increased expression of the impaired ATII cell marker Keratin8. Conclusions: These results suggest that WNT/β-catenin signaling contributes to progenitor cell dysfunction and impaired lung repair in the aged lung, which is further enhanced in IPF.
Post-translational regulation of PGC-1α modulates fibrotic repair.

Jennifer L Larson-Casey,Linlin Gu,Dana Davis,Guo-Qiang Cai,Qiang Ding,Chao He,A Brent Carter

DOI: https://doi.org/10.1096/fj.202100339R

2021-01-01

Abstract:Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease associated with mitochondrial oxidative stress. Mitochondrial reactive oxygen species (mtROS) are important for cell homeostasis by regulating mitochondrial dynamics. Here, we show that IPF BAL cells exhibited increased mitochondrial biogenesis that is, in part, due to increased nuclear expression of peroxisome proliferator-activated receptor-ɣ (PPARɣ) coactivator (PGC)-1α. Increased PPARGC1A mRNA expression directly correlated with reduced pulmonary function in IPF subjects. Oxidant-mediated activation of the p38 MAPK via Akt1 regulated PGC-1α activation to increase mitochondrial biogenesis in monocyte-derived macrophages. Demonstrating the importance of PGC-1α in fibrotic repair, mice harboring a conditional deletion of Ppargc1a in monocyte-derived macrophages or mice administered a chemical inhibitor of mitochondrial division had reduced biogenesis and increased apoptosis, and the mice were protected from pulmonary fibrosis. These observations suggest that Akt1-mediated regulation of PGC-1α maintains mitochondrial homeostasis in monocyte-derived macrophages to induce apoptosis resistance, which contributes to the pathogenesis of pulmonary fibrosis.
Mitochondrial dysfunction contributes to the senescent phenotype of IPF lung fibroblasts

Michael Schuliga,Dmitri V Pechkovsky,Jane Read,David W Waters,Kaj E C Blokland,Andrew T Reid,Cory M Hogaboam,Nasreen Khalil,Janette K Burgess,Cecilia M Prêle,Steven E Mutsaers,Jade Jaffar,Glen Westall,Christopher Grainge,Darryl A Knight

DOI: https://doi.org/10.1111/jcmm.13855

2018-09-26

Journal of Cellular and Molecular Medicine

Abstract:Increasing evidence highlights that senescence plays an important role in idiopathic pulmonary fibrosis (IPF). This study delineates the specific contribution of mitochondria and the superoxide they form to the senescent phenotype of lung fibroblasts from IPF patients (IPF-LFs). Primary cultures of IPF-LFs exhibited an intensified DNA damage response (DDR) and were more senescent than age-matched fibroblasts from control donors (Ctrl-LFs). Furthermore, IPF-LFs exhibited mitochondrial dysfunction, exemplified by increases in mitochondrial superoxide, DNA, stress and activation of mTORC1. The DNA damaging agent etoposide elicited a DDR and augmented senescence in Ctrl-LFs, which were accompanied by disturbances in mitochondrial homoeostasis including heightened superoxide production. However, etoposide had no effect on IPF-LFs. Mitochondrial perturbation by rotenone involving sharp increases in superoxide production also evoked a DDR and senescence in Ctrl-LFs, but not IPF-LFs. Inhibition of mTORC1, antioxidant treatment and a mitochondrial targeting antioxidant decelerated IPF-LF senescence and/or attenuated pharmacologically induced Ctrl-LF senescence. In conclusion, increased superoxide production by dysfunctional mitochondria reinforces lung fibroblast senescence via prolongation of the DDR. As part of an auto-amplifying loop, mTORC1 is activated, altering mitochondrial homoeostasis and increasing superoxide production. Deeper understanding the mechanisms by which mitochondria contribute to fibroblast senescence in IPF has potentially important therapeutic implications.

cell biology,medicine, research & experimental
Modulating in vitro lung fibroblast activation via senolysis of senescent human alveolar epithelial cells

Joseph S Spina,Tracy L Carr,Lucy A Phillips,Heather L Knight,Nancy E Crosbie,Sarah M Lloyd,Manisha A Jhala,Tony J Lam,Jozsef Karman,Meghan E Clements,Tovah A Day,Justin D Crane,William J Housley

DOI: https://doi.org/10.18632/aging.205994

2024-06-29

Abstract:Idiopathic pulmonary fibrosis (IPF) is an age-related disease with poor prognosis and limited therapeutic options. Activation of lung fibroblasts and differentiation to myofibroblasts are the principal effectors of disease pathology, but damage and senescence of alveolar epithelial cells, specifically type II (ATII) cells, has recently been identified as a potential trigger event for the progressive disease cycle. Targeting ATII senescence and the senescence-associated secretory phenotype (SASP) is an attractive therapeutic strategy; however, translatable primary human cell models that enable mechanistic studies and drug development are lacking. Here, we describe a novel system of conditioned medium (CM) transfer from bleomycin-induced senescent primary alveolar epithelial cells (AEC) onto normal human lung fibroblasts (NHLF) that demonstrates an enhanced fibrotic transcriptional and secretory phenotype compared to non-senescent AEC CM treatment or direct bleomycin damage of the NHLFs. In this system, the bleomycin-treated AECs exhibit classical hallmarks of cellular senescence, including SASP and a gene expression profile that resembles aberrant epithelial cells of the IPF lung. Fibroblast activation by CM transfer is attenuated by pre-treatment of senescent AECs with the senolytic Navitoclax and AD80, but not with the standard of care agent Nintedanib or senomorphic JAK-targeting drugs (e.g., ABT-317, ruxolitinib). This model provides a relevant human system for profiling novel senescence-targeting therapeutics for IPF drug development.
The cGAS-STING pathway drives inflammation in Usual Interstitial Pneumonia, phagocytosis could prevent inflammation but is inhibited by the don't eat me signal CD47

Alissa Gruenwald,Margarete Neururer,Sylvia Eidenhammer,Andreas Nerlich,Helmut Popper

DOI: https://doi.org/10.1016/j.prp.2024.155432

Abstract:Background: Usual Interstitial Pneumonia (UIP) a fibrosing pneumonia is associated with idiopathic pulmonary fibrosis, chronic autoimmune disease (AID), or hypersensitivity pneumonia. Oxygen radicals, due to tobacco smoke, can damage DNA and might upregulate PARP1. Cytosolic DNA from dying pneumocytes activate cytosolic GMP-AMP-synthase-stimulator of interferon genes (cGAS-STING) pathway and TREX1. Prolonged inflammation induces senescence, which might be inhibited by phagocytosis, eliminating nuclear debris. We aimed to evaluate activation of cGAS-STING-TREX1 pathway in UIP, and if phagocytosis and anti-phagocytosis might counteract inflammation. Methods: 44 cases of UIP with IPF or AID were studied for the expression of cGAS, pSTING, TREX1 and PARP1. LAMP1 and Rab7 expression served as phagocytosis markers. CD47 protecting phagocytosis and p16 to identify senescent cells were also studied. Results: Epithelial cells in remodeled areas and macrophages expressed cGAS-pSTING, TREX1; epithelia but not macrophages stained for PARP1. Myofibroblasts, endothelia, and bronchial/bronchiolar epithelial cells were all negative except early myofibroblastic foci expressing cGAS. Type II pneumocytes expressed cGAS and PARP1, but less pSTING. TREX1 although expressed was not activated. Macrophages and many regenerating epithelial cells expressed LAMP1 and Rab7. CD47, the 'don't-eat-me-signal', was expressed by macrophages and epithelial cells including senescence cells within the remodeled areas. Conclusions: The cGAS-STING pathway is activated in macrophages and epithelial cells within remodeled areas. LikelyTREX1 because not activated cannot sufficiently degrade DNA fragments. PARP1 activation points to smoking-induced oxygen radical release, prolonging inflammation and leading to fibrosis. By expressing CD47 epithelial cells within remodeled areas protect themselves from being eliminated by phagocytosis.
Regulation of Cellular Senescence Is Independent from Profibrotic Fibroblast-Deposited ECM

Kaj E. C. Blokland,Habibie Habibie,Theo Borghuis,Greta J. Teitsma,Michael Schuliga,Barbro N. Melgert,Darryl A. Knight,Corry-Anke Brandsma,Simon D. Pouwels,Janette K. Burgess

DOI: https://doi.org/10.3390/cells10071628

IF: 6

2021-06-29

Cells

Abstract:Idiopathic pulmonary fibrosis (IPF) is a devastating lung disease with poor survival. Age is a major risk factor, and both alveolar epithelial cells and lung fibroblasts in this disease exhibit features of cellular senescence, a hallmark of ageing. Accumulation of fibrotic extracellular matrix (ECM) is a core feature of IPF and is likely to affect cell function. We hypothesize that aberrant ECM deposition augments fibroblast senescence, creating a perpetuating cycle favouring disease progression. In this study, primary lung fibroblasts were cultured on control and IPF-derived ECM from fibroblasts pretreated with or without profibrotic and prosenescent stimuli, and markers of senescence, fibrosis-associated gene expression and secretion of cytokines were measured. Untreated ECM derived from control or IPF fibroblasts had no effect on the main marker of senescence p16Ink4a and p21Waf1/Cip1. However, the expression of alpha smooth muscle actin (ACTA2) and proteoglycan decorin (DCN) increased in response to IPF-derived ECM. Production of the proinflammatory cytokines C-X-C Motif Chemokine Ligand 8 (CXCL8) by lung fibroblasts was upregulated in response to senescent and profibrotic-derived ECM. Finally, the profibrotic cytokines transforming growth factor β1 (TGF-β1) and connective tissue growth factor (CTGF) were upregulated in response to both senescent- and profibrotic-derived ECM. In summary, ECM deposited by IPF fibroblasts does not induce cellular senescence, while there is upregulation of proinflammatory and profibrotic cytokines and differentiation into a myofibroblast phenotype in response to senescent- and profibrotic-derived ECM, which may contribute to progression of fibrosis in IPF.

cell biology
Transcriptional and Proteomic Characterization of Telomere-Induced Senescence in a Human Alveolar Epithelial Cell Line

Daniel I. Sullivan,Mao Jiang,Angela M. Hinchie,Mark G. Roth,Harinath Bahudhanapati,Mehdi Nouraie,Jie Liu,John F. McDyer,Rama K. Mallampalli,Yingze Zhang,Daniel J. Kass,Toren Finkel,Jonathan K. Alder

DOI: https://doi.org/10.3389/fmed.2021.600626

IF: 3.9

2021-02-09

Frontiers in Medicine

Abstract:Cellular senescence due to telomere dysfunction has been hypothesized to play a role in age-associated diseases including idiopathic pulmonary fibrosis (IPF). It has been postulated that paracrine mediators originating from senescent alveolar epithelia signal to surrounding mesenchymal cells and contribute to disease pathogenesis. However, murine models of telomere-induced alveolar epithelial senescence fail to display the canonical senescence-associated secretory phenotype (SASP) that is observed in senescent human cells. In an effort to understand human-specific responses to telomere dysfunction, we modeled telomere dysfunction-induced senescence in a human alveolar epithelial cell line. We hypothesized that this system would enable us to probe for differences in transcriptional and proteomic senescence pathways in vitro and to identify novel secreted protein (secretome) changes that potentially contribute to the pathogenesis of IPF. Following induction of telomere dysfunction, a robust senescence phenotype was observed. RNA-seq analysis of the senescent cells revealed the SASP and comparisons to previous murine data highlighted differences in response to telomere dysfunction. We conducted a proteomic analysis of the senescent cells using a novel biotin ligase capable of labeling secreted proteins. Candidate biomarkers selected from our transcriptional and secretome data were then evaluated in IPF and control patient plasma. Four novel proteins were found to be differentially expressed between the patient groups: stanniocalcin-1, contactin-1, tenascin C, and total inhibin. Our data show that human telomere-induced, alveolar epithelial senescence results in a transcriptional SASP that is distinct from that seen in analogous murine cells. Our findings suggest that studies in animal models should be carefully validated given the possibility of species-specific responses to telomere dysfunction. We also describe a pragmatic approach for the study of the consequences of telomere-induced alveolar epithelial cell senescence in humans.

medicine, general & internal
Senescent AECⅡ and the Implication for Idiopathic Pulmonary Fibrosis Treatment.

Tingwei Zhang,Jinjin Zhang,Changjun Lv,Hongbo Li,Xiaodong Song

DOI: https://doi.org/10.3389/fphar.2022.1059434

IF: 5.6

2022-01-01

Frontiers in Pharmacology

Abstract:Idiopathic pulmonary fibrosis (IPF) is a chronic and lethal lung disease with limited treatment options. The onset of IPF increases with age, indicating that aging is a major risk factor for IPF. Among the hallmarks of aging, cellular senescence is the primordial driver and primary etiological factor for tissue and organ aging, and an independent risk factor for the progression of IPF. In this review, we focus on the senescence of alveolar type II epithelial cells (AECIIs) and systematically summarize abnormal changes in signal pathways and biological process and implications of senescent AECIIs during IPF progression. Meanwhile, we objectively analyze current medications targeting the elimination of senescent cells or restoration of vitality such as senolytics, senomorphics, autophagy regulators, and stem cell therapy. Finally, we dialectically discuss the feasibility and limitation of targeting senescent AECIIs for IPF treatment. We hope that the understanding will provide new insights to the development of senescent AECII-based approaches for the prevention and mitigation of IPF.
Curculigoside Attenuates Endoplasmic Reticulum Stress-Induced Epithelial Cell and Fibroblast Senescence by Regulating the SIRT1-P300 Signaling Pathway

Weixi Xie,Lang Deng,Rui Qian,Xiaoting Huang,Wei Liu,Siyuan Tang

DOI: https://doi.org/10.3390/antiox13040420

IF: 7.675

2024-03-30

Antioxidants

Abstract:The senescence of alveolar epithelial cells (AECs) and fibroblasts plays a pivotal role in the pathogenesis of idiopathic pulmonary fibrosis (IPF), a condition lacking specific therapeutic interventions. Curculigoside (CCG), a prominent bioactive constituent of Curculigo, exhibits anti-osteoporotic and antioxidant activities. Our investigation aimed to elucidate the anti-senescence and anti-fibrotic effects of CCG in experimental pulmonary fibrosis and delineate its underlying molecular mechanisms. Our findings demonstrate that CCG attenuates bleomycin-induced pulmonary fibrosis and lung senescence in murine models, concomitantly ameliorating lung function impairment. Immunofluorescence staining for senescence marker p21, alongside SPC or α-SMA, suggested that CCG's mitigation of lung senescence correlates closely with the deceleration of senescence in AECs and fibroblasts. In vitro, CCG mitigated H2O2-induced senescence in AECs and the natural senescence of primary mouse fibroblasts. Mechanistically, CCG can upregulate SIRT1 expression, downregulating P300 expression, enhancing Trim72 expression to facilitate P300 ubiquitination and degradation, reducing the acetylation levels of antioxidant enzymes, and upregulating their expression levels. These actions collectively inhibited endoplasmic reticulum stress (ERS) and alleviated senescence. Furthermore, the anti-senescence effects and mechanisms of CCG were validated in a D-galactose (D-gal)-induced progeroid model. This study provides novel insights into the mechanisms underlying the action of CCG in cellular senescence and chronic diseases, offering potential avenues for the development of innovative drugs or therapeutic strategies.

biochemistry & molecular biology,chemistry, medicinal,food science & technology
Griseofulvin treatment of dermatomycoses.

S. Sanders,A. TRINCHAN-PLOU,C. Nelson

1961-03-01

Abstract:
Molecular Mechanisms of Alveolar Epithelial Stem Cell Senescence and Senescence-Associated Differentiation Disorders in Pulmonary Fibrosis

Xiaojing Hong,Lihui Wang,Kexiong Zhang,Jun Liu,Jun-Ping Liu

DOI: https://doi.org/10.3390/cells11050877

IF: 6

2022-03-03

Cells

Abstract:Pulmonary senescence is accelerated by unresolved DNA damage response, underpinning susceptibility to pulmonary fibrosis. Recently it was reported that the SARS-Cov-2 viral infection induces acute pulmonary epithelial senescence followed by fibrosis, although the mechanism remains unclear. Here, we examine roles of alveolar epithelial stem cell senescence and senescence-associated differentiation disorders in pulmonary fibrosis, exploring the mechanisms mediating and preventing pulmonary fibrogenic crisis. Notably, the TGF-β signalling pathway mediates alveolar epithelial stem cell senescence by mechanisms involving suppression of the telomerase reverse transcriptase gene in pulmonary fibrosis. Alternatively, telomere uncapping caused by stress-induced telomeric shelterin protein TPP1 degradation mediates DNA damage response, pulmonary senescence and fibrosis. However, targeted intervention of cellular senescence disrupts pulmonary remodelling and fibrosis by clearing senescent cells using senolytics or preventing senescence using telomere dysfunction inhibitor (TELODIN). Studies indicate that the development of senescence-associated differentiation disorders is reprogrammable and reversible by inhibiting stem cell replicative senescence in pulmonary fibrosis, providing a framework for targeted intervention of the molecular mechanisms of alveolar stem cell senescence and pulmonary fibrosis. Abbreviations: DPS, developmental programmed senescence; IPF, idiopathic pulmonary fibrosis; OIS, oncogene-induced replicative senescence; SADD, senescence-associated differentiation disorder; SALI, senescence-associated low-grade inflammation; SIPS, stress-induced premature senescence; TERC, telomerase RNA component; TERT, telomerase reverse transcriptase; TIFs, telomere dysfunction-induced foci; TIS, therapy-induced senescence; VIS, virus-induced senescence.

cell biology
DNA damage response at telomeres contributes to lung aging and chronic obstructive pulmonary disease

Jodie Birch,Rhys K Anderson,Clara Correia-Melo,Diana Jurk,Graeme Hewitt,Francisco Madeira Marques,Nicola J Green,Elizabeth Moisey,Mark A Birrell,Maria G Belvisi,Fiona Black,John J Taylor,Andrew J Fisher,Anthony De Soyza,João F Passos,Rhys K. Anderson,Nicola J. Green,Mark A. Birrell,Maria G. Belvisi,John J. Taylor,Andrew J. Fisher,João F. Passos

DOI: https://doi.org/10.1152/ajplung.00293.2015

2015-11-15

Abstract:Cellular senescence has been associated with the structural and functional decline observed during physiological lung aging and in chronic obstructive pulmonary disease (COPD). Airway epithelial cells are the first line of defense in the lungs and are important to COPD pathogenesis. However, the mechanisms underlying airway epithelial cell senescence, and particularly the role of telomere dysfunction in this process, are poorly understood. We aimed to investigate telomere dysfunction in airway epithelial cells from patients with COPD, in the aging murine lung and following cigarette smoke exposure. We evaluated colocalization of γ-histone protein 2A.X and telomeres and telomere length in small airway epithelial cells from patients with COPD, during murine lung aging, and following cigarette smoke exposure in vivo and in vitro. We found that telomere-associated DNA damage foci increase in small airway epithelial cells from patients with COPD, without significant telomere shortening detected. With age, telomere-associated foci increase in small airway epithelial cells of the murine lung, which is accelerated by cigarette smoke exposure. Moreover, telomere-associated foci predict age-dependent emphysema, and late-generation Terc null mice, which harbor dysfunctional telomeres, show early-onset emphysema. We found that cigarette smoke accelerates telomere dysfunction via reactive oxygen species in vitro and may be associated with ataxia telangiectasia mutated-dependent secretion of inflammatory cytokines interleukin-6 and -8. We propose that telomeres are highly sensitive to cigarette smoke-induced damage, and telomere dysfunction may underlie decline of lung function observed during aging and in COPD.

physiology,respiratory system
Loss of PTEN induces lung fibrosis via alveolar epithelial cell senescence depending on NF‐κB activation

Yaqiong Tian,Hui Li,Ting Qiu,Jinghong Dai,Yingwei Zhang,Jingyu Chen,Hourong Cai

DOI: https://doi.org/10.1111/acel.12858

IF: 11.005

2018-12-12

Aging Cell

Abstract:Idiopathic pulmonary fibrosis (IPF) is an aging-associated disease with poor prognosis. Currently, there are no effective drugs for preventing the disease process. The mechanisms underlying the role of alveolar epithelial cell (AEC) senescence in the pathogenesis of IPF remain poorly understood. We aimed to explore whether PTEN/NF-κB activated AEC senescence thus resulting in lung fibrosis. First, we investigated the association between the activation of PTEN/NF-κB and cellular senescence in lung tissues from IPF patients. As a result, decreased PTEN, activated NF-κB and increased senescent markers (P21<sup>WAF1</sup> , P16<sup>ink4a</sup> , and SA-β-gal) were found in AECs in fibrotic lung tissues detected by immunohistochemistry (IHC) and immunofluorescence (IF). In vitro experiments showed increased expression levels of senescent markers and augmented senescence-associated secretory phenotype (SASP) in AECs treated with bleomycin (Blm); however, PTEN was reduced significantly following IκB, IKK, and NF-κB activation after stimulation with Blm in AECs. AEC senescence was accelerated by PTEN knockdown, whereas senescence was reversed via NF-κB knockdown and the pharmacological inhibition (BMS-345541) of the NF-κB pathway. Interestingly, we observed increased collagen deposition in fibroblasts cultured with the supernatants collected from senescent AECs. Conversely, the deposition of collagen in fibroblasts was reduced with exposure to the supernatants collected from NF-κB knockdown AECs. These findings indicated that senescent AECs controlled by the PTEN/NF-κB pathway facilitated collagen accumulation in fibroblasts, resulting in lung fibrosis. In conclusion, our study supports the notion that as an initial step in IPF, the senescence process in AECs may be a potential therapeutic target, and the PTEN/NF-κB pathway may be a promising candidate for intervention.

cell biology,geriatrics & gerontology
Late Breaking Abstract - Loss of PTEN induces alveolar epithelial cell senescence resulting in lung fibrosis via activated NF-?B

Yaqiong Tian,Chuanmei Liu,Hui Li,Jinghong Dai,Jingyu Chen,Min Zhou,Hourong Cai

DOI: https://doi.org/10.1183/13993003.congress-2018.OA260

IF: 24.3

2018-01-01

European Respiratory Journal

Abstract:Introduction: Idiopathic pulmonary fibrosis(IPF) is an aging-related disease without effective treatment and underlying mechanisms of alveolar epithelial cell(AEC) senescence remain poorly understood. We aimed to explore whether activated PTEN/NF-κB pathway accelerated AEC senescence thus resulting in lung fibrosis. Methods: Aging markers (p16 and p21), senescence associated-β-gal(SA-β-gal) and activation of PTEN/NF-κB pathway were detected in lung tissues from IPF patients and normal lung tissues. They were also detected in senescent AECs (A549 and rat primary type 2 AEC), which induced by bleomycin. Then human embryonic lung fibroblast(HELF) was cultured with the supernatants of senescent AEC, in which several cytokines (IL-1, IL-6, IL-8 and MMP9) of senescence-associated secretory phenotype(SASP) were tested. Furthermore, gene knock down to PTEN and NF-κB and pharmacological inhibitor(BMS-345541) of NF-κB were applied in AEC. Results: We observed higher expressed p16, p21, SA-β-gal, activated NF-κB and reduced PTEN expression in IPF lung tissues and senescent AECs. And increased SASP cytokines in senescent supernatants and redundant collagen deposition in HELF were found. When PTEN was knocked down, NF-κB was activated, and increased aging markers in AEC and collagen deposition in HELF were observed. Interestingly, AEC aging was relieved by NF-κB inhibitor although PTEN was knock-down. As expected, aging and collagen deposition were rescued by NF-κB knockdown. Conclusions: This study supports that IPF is an aging-related disease, and loss of PTEN activates NF-κB to induce premature senescence of AEC and collagen deposition in fibroblast thus involving in pathogenesis of IPF.
ZLN005 Improves the Protective Effect of Mitochondrial Function on Alveolar Epithelial Cell Aging by Upregulating PGC-1

Miao Ma,Yujuan Gao,Xiaohua Qiu,Xianhua Gui,Yaqiong Tian,Mi Tian,Timothy E. Albertson,Tomoo Kishaba,Yoshinori Tanino,Yuichi Sakairi,Jingyu Chen,Jinghong Dai,Hourong Cai

DOI: https://doi.org/10.21037/jtd-23-815

2023-01-01

Journal of Thoracic Disease

Abstract:Background: Idiopathic pulmonary fibrosis (IPF) is a chronic and fatal pulmonary interstitial disease that usually occurs in the elderly. The senescence of alveolar epithelial cells (AECs) is an important mechanism of IPF. The AECs of patients with IPF have lower expression of peroxisome proliferator-activated receptor-gamma coactivator-1 alpha (PGC-1 alpha), which has been shown to play an important role in maintaining mitochondrial morphology and energy metabolism. This study sought to explore the mechanism by which ZLN005 improves mitochondrial function by upregulating PGC-1 alpha to protect AECs from aging.Methods: Western blot was used to detect the expression of PGC-1 alpha, mitochondrial synthesis protein nuclear respiratory factor-1 (NRF-1), and p21(WAF1) in the lung tissue of the IPF patients and the mice with bleomycin (BLM)-induced pulmonary fibrosis. A549 cells and mice AEC2 cells were treated with hydrogen peroxide (H2O2) to construct cell senescence models. Cell senescence was detected by senescence-associated beta-galactosidase staining. The mitochondrial respiratory function was measured, including the adenosine triphosphate (ATP) generation, reactive oxygen species (ROS) level, changes in cell membrane potential, and energy metabolism. Using lentivirus as a vector and using gene editing technology to over express (upPGC-1 alpha) and knockdown PGC-1 alpha (shPGC-1 alpha) in the A549 cells. The PGC-1 alpha agonist ZLN005 was used to pretreat the A549 and shPGC-1 alpha A549 cells, and cell aging and mitochondrial respiratory function were observed.Results: The Western blot and immunofluorescence assays showed that the expression of PGC-1 alpha and NRF-1 was decreased in the lung tissues of the IPF patients and BLM-induced mice pulmonary fibrosis model, while the expression of p21(WAF1 )was increased. The results of the immunofluorescence and mitochondrial function experiments also indicated that the expression of PGC-1 alpha and mitochondrial synthesis protein NRF-1 were decreased in the senescent cells. Further, the mitochondrial morphology was abnormal and the mitochondrial function was impaired. PGC-1 alpha was involved in the AEC senescence by regulating mitochondrial morphology and function. Treatment with the agonist of PGC-1 alpha (i.e., ZLN005) blocked the H2O2-induced cell senescence by enhancing the expression of PGC-1 alpha.Conclusions: These results provide preliminary insights into the potential clinical application of ZLN005 as a novel therapeutic agent for the treatment of IPF.
ZLN005 improves the protective effect of mitochondrial function on alveolar epithelial cell aging by upregulating PGC-1α

Miao Ma,Yujuan Gao,Xiaohua Qiu,Xianhua Gui,Yaqiong Tian,Mi Tian,Timothy E Albertson,Tomoo Kishaba,Yoshinori Tanino,Yuichi Sakairi,Jingyu Chen,Jinghong Dai,Hourong Cai

DOI: https://doi.org/10.21037/jtd-23-815

2023-11-30

Abstract:Background: Idiopathic pulmonary fibrosis (IPF) is a chronic and fatal pulmonary interstitial disease that usually occurs in the elderly. The senescence of alveolar epithelial cells (AECs) is an important mechanism of IPF. The AECs of patients with IPF have lower expression of peroxisome proliferator-activated receptor-γ coactivator-1 alpha (PGC-1α), which has been shown to play an important role in maintaining mitochondrial morphology and energy metabolism. This study sought to explore the mechanism by which ZLN005 improves mitochondrial function by upregulating PGC-1α to protect AECs from aging. Methods: Western blot was used to detect the expression of PGC-1α, mitochondrial synthesis protein nuclear respiratory factor-1 (NRF-1), and p21WAF1 in the lung tissue of the IPF patients and the mice with bleomycin (BLM)-induced pulmonary fibrosis. A549 cells and mice AEC2 cells were treated with hydrogen peroxide (H2O2) to construct cell senescence models. Cell senescence was detected by senescence-associated beta-galactosidase staining. The mitochondrial respiratory function was measured, including the adenosine triphosphate (ATP) generation, reactive oxygen species (ROS) level, changes in cell membrane potential, and energy metabolism. Using lentivirus as a vector and using gene editing technology to over express (upPGC-1α) and knockdown PGC-1α (shPGC-1α) in the A549 cells. The PGC-1α agonist ZLN005 was used to pretreat the A549 and shPGC-1α A549 cells, and cell aging and mitochondrial respiratory function were observed. Results: The Western blot and immunofluorescence assays showed that the expression of PGC-1α and NRF-1 was decreased in the lung tissues of the IPF patients and BLM-induced mice pulmonary fibrosis model, while the expression of p21WAF1 was increased. The results of the immunofluorescence and mitochondrial function experiments also indicated that the expression of PGC-1α and mitochondrial synthesis protein NRF-1 were decreased in the senescent cells. Further, the mitochondrial morphology was abnormal and the mitochondrial function was impaired. PGC-1α was involved in the AEC senescence by regulating mitochondrial morphology and function. Treatment with the agonist of PGC-1α (i.e., ZLN005) blocked the H2O2-induced cell senescence by enhancing the expression of PGC-1α. Conclusions: These results provide preliminary insights into the potential clinical application of ZLN005 as a novel therapeutic agent for the treatment of IPF.
Antifibrotic Properties of Receptor for Advanced Glycation End Products in Idiopathic Pulmonary Fibrosis.

Hui Ding,XiuHai Ji,Ruhua Chen,Tieliang Ma,Zhiwei Tang,Yan Fen,Hourong Cai

DOI: https://doi.org/10.1016/j.pupt.2015.10.010

IF: 3.282

2015-01-01

Pulmonary Pharmacology & Therapeutics

Abstract:Idiopathic pulmonary fibrosis (IPF) is a progressive chronic interstitial lung disease with poor survival. Previous reports suggested the contributory effect of receptor for advanced glycation end products (RAGE) to the pathogenesis of IPF. But the findings are controversial. The present in vivo study with RAGE null mice, we further confirmed the evidence that lack of RAGE evolves worse bleomycin-induced pulmonary fibrosis compared with control mice. Moreover, RAGE null mice spontaneously developed similar pathogenesis of lung fibrosis via immunohistochemical staining. In addition, we investigated the negative roles of RAGE on epithelial-mesenchymal transition (EMT) indicated by elevated alpha-smooth muscle actin (alpha-SMA) and collagen-I (Col-I) deposition in A549 cell treated with transforming growth factor-beta (TGF-beta), all of which were blocked by sRAGE, a decoy receptor. Furthermore, interacting with the specific ligand as AGE, RAGE blocked TGF-beta-induced activation of Smad2, ERR and JNK signals in A549 cells, which were also challenged by sRAGE administration. This present study confirmed an important role Of RAGE in vivo and vitro models of pulmonary fibrosis and suggested the therapeutic possibility for pulmonary fibrosis via RAGE regulation. (C) 2015 Elsevier Ltd. All rights reserved.
The role of cGAS-STING signaling in pulmonary fibrosis and its therapeutic potential

Jing Zhang,Lanlan Zhang,Yutian Chen,Xiaobin Fang,Bo Li,Chunheng Mo

DOI: https://doi.org/10.3389/fimmu.2023.1273248

IF: 7.3

2023-10-25

Frontiers in Immunology

Abstract:Pulmonary fibrosis is a progressive and ultimately fatal lung disease, exhibiting the excessive production of extracellular matrix and aberrant activation of fibroblast. While Pirfenidone and Nintedanib are FDA-approved drugs that can slow down the progression of pulmonary fibrosis, they are unable to reverse the disease. Therefore, there is an urgent demand to develop more efficient therapeutic approaches for pulmonary fibrosis. The intracellular DNA sensor called cyclic guanosine monophosphate-adenosine monophosphate (cGAMP) synthase (cGAS) plays a crucial role in detecting DNA and generating cGAMP, a second messenger. Subsequently, cGAMP triggers the activation of stimulator of interferon genes (STING), initiating a signaling cascade that leads to the stimulation of type I interferons and other signaling molecules involved in immune responses. Recent studies have highlighted the involvement of aberrant activation of cGAS-STING contributes to fibrotic lung diseases. This review aims to provide a comprehensive summary of the current knowledge regarding the role of cGAS-STING pathway in pulmonary fibrosis. Moreover, we discuss the potential therapeutic implications of targeting the cGAS-STING pathway, including the utilization of inhibitors of cGAS and STING.

immunology

MEASUREMENTS OF CELLULAR VIABILITY: A COMPARATIVE STUDY OF NEUTRAL RED AND RADIOACTIVE SULFATE IN THE EXAMINATION OF THE VIABILITY OF CARTILAGE

The Potentially Therapeutic Role of EPAC in Curbing the Process of Idiopathic Pulmonary Fibrosis Via Differential Cellular Pathways

Aged alveolar epithelium contributes to inflammaging and reduced stem cell function in the lung

Prolonged WNT/ß-catenin signaling induces cellular senescence in aging and pulmonary fibrosis

Post-translational regulation of PGC-1α modulates fibrotic repair.

Mitochondrial dysfunction contributes to the senescent phenotype of IPF lung fibroblasts

Modulating in vitro lung fibroblast activation via senolysis of senescent human alveolar epithelial cells

The cGAS-STING pathway drives inflammation in Usual Interstitial Pneumonia, phagocytosis could prevent inflammation but is inhibited by the don't eat me signal CD47

Regulation of Cellular Senescence Is Independent from Profibrotic Fibroblast-Deposited ECM

Transcriptional and Proteomic Characterization of Telomere-Induced Senescence in a Human Alveolar Epithelial Cell Line

Senescent AECⅡ and the Implication for Idiopathic Pulmonary Fibrosis Treatment.

Curculigoside Attenuates Endoplasmic Reticulum Stress-Induced Epithelial Cell and Fibroblast Senescence by Regulating the SIRT1-P300 Signaling Pathway

Griseofulvin treatment of dermatomycoses.

Molecular Mechanisms of Alveolar Epithelial Stem Cell Senescence and Senescence-Associated Differentiation Disorders in Pulmonary Fibrosis

DNA damage response at telomeres contributes to lung aging and chronic obstructive pulmonary disease

Loss of PTEN induces lung fibrosis via alveolar epithelial cell senescence depending on NF‐κB activation

Late Breaking Abstract - Loss of PTEN induces alveolar epithelial cell senescence resulting in lung fibrosis via activated NF-?B

ZLN005 Improves the Protective Effect of Mitochondrial Function on Alveolar Epithelial Cell Aging by Upregulating PGC-1

ZLN005 improves the protective effect of mitochondrial function on alveolar epithelial cell aging by upregulating PGC-1α

Antifibrotic Properties of Receptor for Advanced Glycation End Products in Idiopathic Pulmonary Fibrosis.

The role of cGAS-STING signaling in pulmonary fibrosis and its therapeutic potential